Search research articles
Contact Us
Filters
Showing results (61-70 of 8,403) with videos related to
Page
of 841
Sort By:
Biomedical Instrumentation & Technology
|
January 20, 2018
Thing Two and Thing One
Axel Wirth
Physics in Medicine and Biology
|
January 1, 1989
Effective energy resolution and scatter rejection in nuclear medicine
V Wirth
MMW Fortschritte Der Medizin
|
February 22, 2018
A Wirth
MMW Fortschritte Der Medizin
|
December 13, 2017
Alfred Wirth
MMW Fortschritte Der Medizin
|
July 3, 2016
[Not Available]
A Wirth
Urologia Internationalis
|
January 1, 1991
The current use of interferons, interleukin-2 and tumor necrosis factor in renal cell cancer
M Wirth
Der Urologe. Ausg. A
|
May 1, 1991
[The value of prostate-specific antigen]
M Wirth
Deutsche Medizinische Wochenschrift (1946)
|
October 19, 1984
[Herpes simplex encephalitis]
K Wirth
MMW Fortschritte Der Medizin
|
May 28, 2015
[Every second obese teenager at risk for coronary heart disease]
A Wirth
Diabetes, Obesity & Metabolism
|
January 12, 2005
Reduction of body weight and co-morbidities by orlistat: The XXL--Primary Health Care Trial
A Wirth
Page
of 841
Search research articles
Search
Showing results (61-70 of 8,403) with videos related to
Sort By:
Page
of 841
Biomedical Instrumentation & Technology
|
January 20, 2018
Thing Two and Thing One
Axel Wirth
Physics in Medicine and Biology
|
January 1, 1989
Effective energy resolution and scatter rejection in nuclear medicine
V Wirth
MMW Fortschritte Der Medizin
|
February 22, 2018
A Wirth
MMW Fortschritte Der Medizin
|
December 13, 2017
Alfred Wirth
MMW Fortschritte Der Medizin
|
July 3, 2016
[Not Available]
A Wirth
Urologia Internationalis
|
January 1, 1991
The current use of interferons, interleukin-2 and tumor necrosis factor in renal cell cancer
M Wirth
Der Urologe. Ausg. A
|
May 1, 1991
[The value of prostate-specific antigen]
M Wirth
Deutsche Medizinische Wochenschrift (1946)
|
October 19, 1984
[Herpes simplex encephalitis]
K Wirth
MMW Fortschritte Der Medizin
|
May 28, 2015
[Every second obese teenager at risk for coronary heart disease]
A Wirth
Diabetes, Obesity & Metabolism
|
January 12, 2005
Reduction of body weight and co-morbidities by orlistat: The XXL--Primary Health Care Trial
A Wirth
Page
of 841